The American Healthcare Refugee: Why 2M+ Americans Sought Care Abroad This Year

They are not vacationers. They are not medical tourists seeking discount nose jobs. They are Americans — with jobs, with insurance (some of them), with lives that look perfectly normal from the outside — who have concluded that the US healthcare system cannot or will not serve them at a price they can survive.

And there are millions of them.

The Numbers

An estimated 2 million Americans traveled abroad for medical care in the past year. That number has been growing 15–25% annually. The global medical tourism market is projected to reach $207 billion by 2027.

Behind those numbers:

• $220 billion in total US medical debt outstanding
• 100 million Americans burdened by medical bills
• 500,000+ medical-debt-related bankruptcies annually — the #1 cause of personal bankruptcy in America
• 27 million Americans uninsured as of 2024, with that number rising as ACA enhanced subsidies expired and Medicaid unwinding continued
• 36% of American adults delayed or skipped medical care in the past year due to cost

These are not fringe statistics. This is the mainstream American healthcare experience for a significant portion of the population.

Who Is Going Abroad — and Why

The medical tourism patient is not who you might picture. The stereotype — a wealthy person seeking elective cosmetic surgery at a beach resort — represents only a fraction of the market. The fastest-growing segments are:

The insured-but-exposed. Americans with employer health insurance who face $5,000–$15,000 deductibles. When a knee replacement costs $30,000–$50,000 and insurance does not kick in until you have spent $8,000 out of pocket, flying to Colombia for $7,000 all-in makes pure economic sense — even for people with "good" insurance.

The dental gap. Dental insurance in the US is notoriously inadequate. Annual maximums of $1,000–$2,000 cover routine cleanings but are meaningless against a $20,000 All-on-4 implant need. Dental tourism is the fastest-growing segment because the coverage gap is the widest.

The fertility desert. IVF costs $15,000–$30,000 per cycle in the US, and most insurance plans do not cover it. Couples facing multiple cycles are looking at $50,000–$100,000. IVF in Colombia at $3,500–$7,000 per cycle changes the math entirely — and sometimes makes the difference between having a child and not.

The innovation seekers. Stem cell therapy for joint degeneration, autoimmune conditions, and neurological disorders is either unavailable or prohibitively experimental in the US. Countries like Colombia operate within regulatory frameworks that allow access to treatments that American patients simply cannot get at home.

The Structural Problem

Medical tourism is not a market failure — it is a market response to a deeper structural failure. The US spends more per capita on healthcare than any country in the world ($12,500+ per person annually) and produces outcomes that rank below dozens of countries that spend a fraction as much.

Colombia, ranked #22 by the WHO for healthcare system performance, spends approximately $1,100 per capita. The US, ranked #37, spends eleven times more. This disparity is not explained by quality differences — it is explained by administrative bloat, pharmaceutical pricing, hospital monopolization, and an insurance-intermediary model that adds cost at every layer without proportionate value.

When a patient can fly to Medellín, stay for two weeks, have a procedure performed by a board-certified surgeon at a JCI-accredited hospital, recover in a dedicated nursing facility, fly home, and still spend less than the out-of-pocket cost of the same procedure at their local hospital — the system is telling them something.

What This Means Going Forward

Medical tourism is no longer an anomaly. It is an established, growing, and increasingly sophisticated alternative for Americans priced out of their own healthcare system. The quality of international medical care — particularly in countries like Colombia, Thailand, and Turkey — has reached a point where the quality argument against going abroad no longer holds for most procedures at accredited facilities.

The remaining barriers are informational (most Americans do not know this option exists), logistical (planning is complex), and psychological (the idea of surgery abroad feels risky). Those barriers are falling quickly as the economics continue to push people toward solutions that actually work for them.